Dorada et al. using IHC to detect TYMS expression, examined 120 tumours diagnosed with stage II CRC of which 50% had received chemotherapy after surgery [68] and validated the findings using real-time qRT-PCR demonstrating that adjuvant chemotherapy improved OS (p = 0.04) of the cohort. This evidence concerns the gene TYMS and colorectal carcinoma.